TAM
ELV icon

Trillium Asset Management’s Elevance Health ELV Stock Holding History

Trillium Asset Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.06M Sell
20,852
-1,450
-7% -$538K 0.25% 90
2026
Q1 		$6.44M Sell
22,302
-288
-1% -$94.7K 0.21% 97
2025
Q4 		$7.92M Sell
22,590
-6,846
-23% -$2.31M 0.24% 94
2025
Q3 		$9.51M Sell
29,436
-2,908
-9% -$904K 0.25% 93
2025
Q2 		$12.6M Sell
32,344
-679
-2% -$273K 0.34% 80
2025
Q1 		$14.4M Sell
33,023
-40,511
-55% -$16.3M 0.41% 72
2024
Q4 		$27.1M Sell
73,534
-26,985
-27% -$11.3M 0.7% 46
2024
Q3 		$52.3M Buy
100,519
+14,769
+17% +$7.89M 1.28% 15
2024
Q2 		$46.5M Sell
85,750
-1,316
-2% -$696K 1.17% 21
2024
Q1 		$45.1M Buy
87,066
+116
+0.1% +$57.7K 1.15% 21
2023
Q4 		$41M Sell
86,950
-16,514
-16% -$7.64M 1.12% 24
2023
Q3 		$45M Sell
103,464
-1,022
-1% -$464K 1.36% 16
2023
Q2 		$46.4M Sell
104,486
-10,397
-9% -$4.8M 1.3% 16
2023
Q1 		$53.7M Sell
114,883
-1,417
-1% -$674K 1.57% 10
2022
Q4 		$59.7M Sell
116,300
-2,933
-2% -$1.49M 1.84% 6
2022
Q3 		$54.2M Sell
119,233
-992
-0.8% -$475K 1.77% 6
2022
Q2 		$57.9M Buy
120,225
+10,717
+10% +$5.3M 1.78% 6
2022
Q1 		$53.8M Sell
109,508
-7,685
-7% -$3.51M 1.43% 9
2021
Q4 		$54.3M Buy
117,193
+7,384
+7% +$3.11M 1.27% 15
2021
Q3 		$40.9M Buy
109,809
+24,709
+29% +$9.39M 1.08% 23
2021
Q2 		$32.4M Buy
85,100
+3,679
+5% +$1.41M 0.9% 37
2021
Q1 		$29.2M Buy
81,421
+12,186
+18% +$3.92M 0.92% 34
2020
Q4 		$22.2M Buy
69,235
+7,185
+12% +$2.2M 0.8% 47
2020
Q3 		$16.7M Sell
62,050
-5,207
-8% -$1.4M 0.7% 50
2020
Q2 		$17.7M Buy
+67,257
New +$17.9M 0.76% 47

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Trillium Asset Management's ELV Position: Q2 2026 in Review

Trillium Asset Management reduced its Elevance Health (ELV) stake by 6.5% in Q2 2026, selling an estimated $538K and leaving 20,852 shares worth $8.06M. The position accounts for 0.25% of the portfolio, ranked #90.

Trillium Asset Management first reported a position in ELV in Q2 2020 and has held it in 25 quarters since. The position peaked at $59.7M in Q4 2022. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Trillium Asset Management held 20,852 shares of Elevance Health worth $8.06M as of Q2 2026.
  • Trillium Asset Management sold 1,450 Elevance Health shares in Q2 2026, an estimated $538K.
  • Elevance Health made up 0.25% of Trillium Asset Management's portfolio in Q2 2026, its #90 holding.
  • Trillium Asset Management first reported a position in Elevance Health in Q2 2020 and has held it in 25 quarters since.
  • Trillium Asset Management's Elevance Health position peaked at $59.7M in Q4 2022.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Trillium Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.